Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PhRMA Quality Of LIfe Measurement Recommendations Expected in July

Executive Summary

The Pharmaceutical Research & Manufacturers of America Health Outcomes Working Group is compiling health-related quality of life measurement recommendations in a report for industry.

You may also be interested in...



Medicare Rx Benefit Would Lead U.S. To Form Agency Like UK's NICE - FDAer

A Medicare drug benefit would create the need for a government organization similar to the U.K.' s National Institute for Clinical Excellence, Division of Drug Marketing, Advertising & Communications Branch Chief Laurie Burke suggested May 24.

Medicare Rx Benefit Would Lead U.S. To Form Agency Like UK's NICE - FDAer

A Medicare drug benefit would create the need for a government organization similar to the U.K.' s National Institute for Clinical Excellence, Division of Drug Marketing, Advertising & Communications Branch Chief Laurie Burke suggested May 24.

Industry Active Role In Guidance Development Urged By Wyeth's Burlington

Regulated industry should take a more aggressive approach to writing guidances, Wyeth-Ayerst Senior VP-Global Regulatory Affairs Bruce Burlington, PhD, told a Parenteral Drugs Association/FDA joint conference Sept. 29 in Bethesda, Md.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS034264

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel